Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
102.00    0.20 (0.20%)
Bid:
102.40
Ask:
102.80
Spread: 0.40 (0.391%)
Market Cap: £167.22m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

12 May 2011 07:00

RNS Number : 4433G
Yule Catto & Co PLC
12 May 2011
 



12 May 2011

 

Yule Catto & Co plc (the "Group") 

 

Interim Management Statement

 

At this afternoon's AGM of Yule Catto & Co plc, the international producer of speciality chemicals, Chairman Peter Wood will make the following statement which also comprises the Group's interim management statement for the period 1 January 2011 to date.

 

The Group's earnings for the first quarter were well ahead of the same period last year excluding any impact of the PolymerLatex acquisition, and the Board's expectations for financial performance for 2011 remain unchanged.

 

Overall demand in Yule Catto's Polymer business was solid. Asian demand was strong through the quarter, whilst Europe firmed after a slow start in the UK. Ongoing very substantial monomer price increases have had to be passed on to customers, resulting in the usual temporary margin compression as the increases are recovered and target unit margins per tonne restored. Consequently, although volumes increased in Polymers and turnover was strongly ahead, operating profit was flat year on year in the first quarter. Whilst Europe lagged the prior year, Asia was ahead, despite, as expected, profits being temporarily constrained by capacity during the quarter. This position will be resolved in the course of the second quarter with the new 15,000 tonne nitrile expansion coming on line and some spare capacity in the acquired PolymerLatex nitrile assets. In April, the existing Yule Catto polymer business performed ahead of prior year.

 

The acquisition of PolymerLatex completed at the end of March as anticipated. Integration planning progressed through the first quarter and is now being implemented. Post acquisition, the synergy potential has been confirmed, and management remain highly confident that at least £20m of synergies will be delivered as disclosed at the time of the acquisition announcement and to the same timetable. Regular updates on progress in delivering these synergies will be provided to investors, with the first update to be delivered with the group's half year results in August. As at the date of this statement, actions taken to date have already delivered synergies with an annual run rate value of approximately £2m.

 

PolymerLatex itself traded comfortably ahead of last year in the first quarter, and this has continued through April. The business benefited from good demand in central Europe for latex and volume growth in its Malaysian nitrile facility. Plans are already being developed for very substantial increases in capacity in Asia for nitrile and SBR latex to be brought on line before the end of 2012.

 

In the Group's other businesses in the first quarter, the Pharma division performed well ahead of what was a very weak result in the same period last year, whilst William Blythe continued to grow profits strongly.

 

Net debt at the end of the quarter stood at £235m reflecting the impact of the acquisition of PolymerLatex, in line with the Group's forecasts at the time of the acquisition announcement.

 

- Ends -

 

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

David Blackwood, Group Finance Director

MHP Communications

Tel: 020 3128 8100

Andrew Jaques

John Olsen

Ian Payne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLFFLFERILLIL
Date   Source Headline
6th Nov 20084:37 pmRNSPrice Monitoring Extension
21st Oct 20086:24 pmRNSHolding(s) in Company
21st Oct 20086:24 pmRNSHolding(s) in Company
8th Sep 20084:41 pmRNSSecond Price Monitoring Extn
8th Sep 20084:36 pmRNSPrice Monitoring Extension
2nd Sep 200812:26 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
14th Aug 20088:59 amRNSNotice of Results
12th Aug 20087:00 amRNSSale Completion
5th Aug 20089:42 amRNSBlocklisting Interim Review
1st Aug 200812:03 pmRNSHolding(s) in Company
21st Jul 20087:00 amRNSDisposal
27th Jun 20087:00 amRNSSale Completion
26th Jun 200810:17 amRNSHolding(s) in Company
18th Jun 200811:44 amRNSHolding(s) in Company
17th Jun 200810:12 amRNSDirector/PDMR Shareholding
16th Jun 20085:14 pmRNSDirector/PDMR Shareholding
16th Jun 200810:33 amRNSDirector/PDMR Shareholding
2nd Jun 20082:57 pmRNSBlocklisting Interim Review
30th May 20082:37 pmRNSSale Completion
15th May 20084:17 pmRNSResult of AGM
15th May 20087:00 amRNSTrading Update
9th May 20081:44 pmRNSHolding(s) in Company
24th Apr 20083:00 pmRNSAnnual Information Update
14th Apr 20084:43 pmRNSAnnual Report and Accounts
8th Apr 20089:55 amRNSDirector/PDMR Shareholding
7th Apr 20084:30 pmRNSHolding(s) in Company
14th Mar 200811:48 amRNSDirector/PDMR Shareholding
14th Mar 200811:46 amRNSDirector/PDMR Shareholding
12th Mar 20087:00 amRNSFinal Results
11th Feb 20082:40 pmRNSBlocklisting Interim Review
11th Feb 20087:01 amRNSDisposal
14th Dec 20077:00 amRNSPre-close Trading Statement
30th Nov 20073:37 pmRNSBlocklisting Interim Review
28th Nov 20072:46 pmRNSHolding(s) in Company
22nd Nov 20074:25 pmRNSDirector/PDMR Shareholding
24th Sep 200710:00 amRNSGroup Finance Director
6th Sep 20077:01 amRNSInterim Results
21st Aug 20077:00 amRNSBoard Appointments
14th Aug 20079:30 amRNSHolding(s) in Company
8th Aug 200712:16 pmRNSHolding(s) in Company
1st Aug 20077:01 amRNSPlant reorganisation
24th Jul 20072:05 pmRNSHolding(s) in Company
20th Jul 20073:50 pmRNSHolding(s) in Company
13th Jul 200712:47 pmRNSHolding(s) in Company
22nd Jun 200711:16 amRNSHolding(s) in Company
1st Jun 200711:25 amRNSBlocklisting Interim Review
1st Jun 20077:01 amRNSDivisional restructuring
29th May 20072:44 pmRNSHolding(s) in Company
17th May 20074:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.